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Marine mammals are exposed to ischemia/reperfusion and hypoxia/reoxygenation
during diving. During oxygen deprivation, adenosine triphosphate (ATP) breakdown
implies purine metabolite accumulation, which in humans is associated with
pathological conditions. Purine recycling in seals increases in response to prolonged
fasting and ischemia. Concentrations of metabolites and activities of key enzymes
in purine metabolism were examined in plasma and red blood cells from
bottlenose dolphins (Tursiops truncatus) and humans. Hypoxanthine and inosine
monophosphate concentrations were higher in plasma from dolphins than humans.
Plasma hypoxanthine-guanine phosphoribosyl transferase (HGPRT) activity in dolphins
suggests an elevated purine recycling rate, and a mechanism for avoiding accumulation
of non-recyclable purines (xanthine and uric acid). Red blood cell concentrations of
hypoxanthine, adenosine diphosphate, ATP and guanosine triphosphate were lower
in dolphins than in humans; adenosine monophosphate and nicotinamide adenine
dinucleotide concentrations were higher in dolphins. HGPRT activity in red blood cells
was higher in humans than in dolphins. The lower concentrations of purine catabolism
and recycling by-products in plasma from dolphins could be beneficial in providing
substrates for recovery of ATP depleted during diving or vigorous swimming. These
results suggest that purine salvage in dolphins could be a mechanism for delivering
nucleotide precursors to tissues with high ATP and guanosine triphosphate requirements.
Keywords: bottlenose dolphin, diving, hypoxia, ischemia, purine metabolism, purine salvage
INTRODUCTION
Purine bases and nucleotides are essential for the appropriate performance of metabolic functions,
such as cellular signaling and energy transfer, and as constituents of nucleic acids in all living
organisms (Traut, 1994; Baranowska-Bosiacka et al., 2004). Purine metabolism includes closely
interrelated synthesis (de novo), salvage and catabolism pathways (van den Berghe et al., 2012)
López-Cruz et al. Purine Metabolism in Dolphins and Humans
(Figure 1). During episodes of ischemia or hypoxia, adenosine
triphosphate (ATP) reserves are depleted and hydrolyzed to
hypoxanthine (HX); accumulation of HX is associated with
reperfusion injury mediated by reactive oxygen species (Rao
et al., 1990; Marro et al., 1997). Xanthine oxidase (XO) produces
xanthine and uric acid from HX (Nelson and Cox, 2008). Inborn
errors of purine metabolism are characterized by abnormal
levels of purine metabolites in cells or body fluids, increases
or decreases in purine metabolites are related to alterations in
activity from enzymes related to purine biosynthesis, purine
salvage and purine catabolism (van Gennip, 1999; van den
Berghe et al., 2012). Disorders of purine metabolism are
related to several clinical signs: arthritis, ataxia, recurrent
infections, convulsions, growth retardation, etc. (van den Berghe
et al., 2012). Hyperuricemia and gout are among the common
pathologies associated to purine disorders, increased synthesis
and decreased excretion of uric acid (the final product of
purine metabolism in humans) are the main causes of these
conditions (Curto et al., 1998). Accumulation of uric acid and
decreased activities of enzymes involved in the purine salvage
pathway, such as purine nucleoside phosphorylase (PNP) and
hypoxanthine-guanine phosphoribosyl transferase (HGPRT), are
related with metabolic disorders including hyperuricemia, gout,
immunological disorders, neurologic abnormalities and Lesch-
Nyhan syndrome, some of which are known to cause early death
in humans (Fox, 1981; Curto et al., 1998; Skinner et al., 2006;
Torres and Puig, 2007; Jurecka, 2009). In order to avoid uric
acid and xanthine overproduction, inhibition of xanthine oxidase
activity with allopurinol is recommended (van den Berghe et al.,
2012). In non-primate mammals, such as seals and dolphins, the
enzyme uricase catalyzes uric acid to allantoin (Skinner et al.,
2006).
Marine mammals are exposed to ischemia/reperfusion and
hypoxia/reoxygenation cycles during diving as a part of their
life history. The physiological adaptations to breath-hold diving
in marine mammals have been well described (Kooyman and
Ponganis, 1998; Kanatous et al., 2002). In general, tissues
from marine mammals have higher capacities to produce
superoxide radical as a consequence of ischemia/reperfusion
cycles associated to diving (Zenteno-Savín et al., 2002; Vázquez-
Medina et al., 2007). However, oxidative damage is avoided,
in part due to constitutively higher antioxidant capacities in
marine mammal tissues and erythrocytes (red blood cells,
RBC) (Wilhelm-Filho et al., 2002; Zenteno-Savín et al., 2012).
Purine recycling by inosine monophosphate (IMP)-HGPRT
pathway has been suggested in liver and heart from ringed
seals after the evidence of HX accumulation caused by ischemia
(Elsner et al., 1998). Avoidance of HX accumulation could
represent an advantage to reduce reactive oxygen species (ROS)
production associated to XO activity. However, knowledge of
purine metabolism in these aquatic organisms is still incomplete.
Concentrations of HX following experimental ischemia in kidney
and heart from ringed seal (Phoca hispida) are lower than from
domestic pig (Sus scrofa) (Elsner et al., 1998). Prolonged fasting
increases the expression and activities of HGPRT and XO in
northern elephant seals, suggesting an efficient purine recycling
and catabolism throughout the fasting period (Soñanez-Organis
et al., 2012), which includes frequent occurrence of sleep apnea
(Tift et al., 2013). PNP activity in RBC from bottlenose dolphins
(Tursiops truncatus) is lower than in humans (López-Cruz
et al., 2014); therefore, a lower conversion rate from inosine
to HX may suggest that bottlenose dolphins avoid reperfusion
injury associated to the HX-XO system. Since seals can be
considered semiaquatic mammals, we addressed the question
of a potential enhancement of purine recycling in a fully
aquatic mammal, the bottlenose dolphin, as an adaptation to
breath-hold diving. In this study, we compared the principal
indicators of purine metabolism pathways between a terrestrial
mammal, in which purine disorders are well characterized, and
a totally aquatic mammal without previous evidence of purine
metabolism enhancements and without prolonged fasting or
ischemia conditions.
MATERIALS AND METHODS
Chemicals and Standards
All the chromatographic standards for purine metabolite
determinations were HPLC grade. All solutions were prepared
using ultrapure water obtained from a Milli-Q water purification
system (Millipore, Bedford, MA, USA). Monobasic potassium
phosphate was obtained from Sigma-Aldrich Chemical Co.
(St Louis, MO, USA), xanthosine monophosphate (XMP) was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA), while acetonitrile (HPLC grade), perchloric acid and
potassium hydroxide were obtained from J.T. Baker (Phillisburg,
NJ, USA). Potassium carbonate was purchased from Productos
Químicos Monterrey (Monterrey, Nuevo Leon, Mexico).
Instrumentation
Ion-pair high performance liquid chromatography was carried
out in a system (Waters 2695, Milford, MA, USA) consisting of
an autosampler, quaternary gradient pump solvent management
system, on-line degasser and column heater, with a photodiode
array detector (PDA, Waters 2996). Chromatography data were
acquired and processed using EmpowerTM software.
Subjects, Sample Collection, and Handling
Blood samples from 12 human volunteers (8 females, 4 males;
33.1 ± 4.9 years old, 62.6 ± 11.39 kg body mass) were collected.
All individuals were informed and oriented regarding clinical
procedures, written consent was obtained prior to sample
collection. Blood samples were collected from 12 bottlenose
dolphins (7 females, 5 males; 9.3 ± 3.9 years old, 190.8 ±
31.5 kg body mass) under human care. Additionally, 8 blood
samples from dolphins were collected in order to determine
plasma uricase activity. In dolphins, blood sampling procedures
require a ventral position and the organisms were at static
apnea; sampling procedure lasted between 1 and 5 min. All
samples were collected from healthy individuals following an
overnight fast. No pregnant or lactating organisms were included
in this study. Human samples were obtained at a local hospital
(volunteers who attended as altruist donors to the blood
bank of the local hospital). Bottlenose dolphin samples were
collected at Cabo Dolphins, San José del Cabo and Cabo San
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FIGURE 1 | Simplified scheme of purine metabolism pathways. 5-phosphoribosyl 1-pyrophosphate (PRPP), inosine monophosphate (IMP), guanosine
monophosphate (GMP), adenosine monophosphate (AMP). Dark boxes enclose enzymes involved in de novo synthesis, purine salvage and catabolism pathways.
Purine nucleoside phosphorylase (PNP), hypoxanthine-guanine phosphorybosil transferase (HGPRT), adenine phosphorybosiltransferase (APRT), xanthine oxidase
(XO) inosine monophosphate dehydrogenase (IMPDH). Modified from Torres and Puig (2007).
Lucas, Baja California Sur, Mexico. Sampling and experimental
procedures were reviewed and approved by the local hospital
ethics committee and by the Capítulo Baja California Sur de la
Academia Nacional Mexicana de Bioética, A.C. Peripheral blood
samples were collected as previously reported (López-Cruz et al.,
2014) and transported to the laboratory immediately. Plasma was
recovered by centrifugation at 1500 × g during 5 min at 25◦C.
RBC were obtained as described by Montero et al. (1995).
Sample Preparation, Standards and
Chromatographic Procedures for Purine
Metabolites Determination
Purine metabolites were extracted from RBC following the
methods described by Giannattasio et al. (2003) with minor
modifications. Briefly, RBC were disrupted with cold distilled
water (1:6, v/v) and frozen/thawed twice. Intraerythrocytic
content was deproteinized with cold perchloric acid (HClO4,
0.5M), shaken vigorously, incubated on an ice bath for 10 min,
and centrifuged at 17,900 × g for 15min at 4◦C. Potassium
hydroxide (KOH, 0.5M) and potassium phosphate (KH2PO4, 0.1
M, pH 6.5) were added, and the samples were incubated on an ice
bath for 10min; pH was adjusted to 6–7. Potassium perchlorate
was removed by centrifugation at 17,900 × g for 15 min at
4◦C. Supernatant was filtered (0.22µM, SLGVR04NL, Millipore)
and samples were immediately analyzed. Plasma samples were
treated as reported by Stocchi et al. (1987). Briefly, plasma
(500 µL) was filtered using a 50 kDa molecular weight filter
(Amicon Ultra-4, Millipore) by centrifugation at 2739 × g for
15min at 4◦C. The cleared filtered solution was analyzed by
HPLC. Standards, solutions and chromatographic procedures
were as suggested by Giannattasio et al. (2003) with some
modifications. HX, inosine, IMP, NAD+, adenosine, adenosine
monophosphate (AMP), adenosine diphosphate (ADP), ATP,
GDP, guanosine triphosphate (GTP) were dissolved in KH2PO4
(0.1M), xanthine and uric acid were prepared in NaOH (40mM).
Amixture including known concentrations of all metabolites was
used to prepare a standard curve (1.56–100 µM). A supelcosil
LC-18, 150 × 4.6mm, 3 µm particle size column (Supelco,
USA) was used as the stationary phase. Mobile phase consisted
of buffer A (100 mM KH2PO4, 8 mM tetrabutylammonium
hydrogen sulfate, pH 6.0) and buffer B (100mM KH2PO4, 8mM
tetrabutylammonium hydrogen sulfate with 30% acetonitrile, pH
6.0). Sample analysis was performed using a binary gradient from
100% buffer A to 100% buffer B in a total run time of 25min at
constant flow rate of 1.5mL min−1 at 25◦C. A volume of 40 µL
was injected of the standard curve and samples. Detection signal
was monitored at 254 nm.
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Enzyme Activity
The activity of hypoxanthine-guanine phosphoribosyl transferase
(EC 2.4.2.8, HGPRT) was measured in plasma and RBC samples
by using a PRECICE R© HPRT assay kit (NovoCIB, Lyon, France)
following manufacturer’s instructions. One unit of HGPRT
activity is defined as the amount of enzyme that catalyzes the
conversion of 1 µM of HX to IMP per minute at pH 8.8 at 25◦C.
Human recombinant HGPRT was used as a positive control.
Results are expressed as nmol h−1 mg−1 of protein.
The activity of inosine monophosphate dehydrogenase
(EC 1.1.1.205, IMPDH) was measured by quantifying the
concentration of xanthosine monophosphate (XMP) using
HPLC. RBC samples were treated as described by Montero et al.
(1995) and assay conditions were as reported by Glander et al.
(2001). Briefly, RBC were disrupted with cold distilled water
and dithiothreitol (DTT, 1 M), 1:2 v/v, frozen and thawed twice.
Assay reaction was started by adding 50 µL of intraerythrocytic
content to 120 µL of the reaction mixture (IMP, 1 mM;
NAD+, 0.5 mM; Na3PO4, 40 mM; KCl 100 mM; pH 7.4).
After 2.5 h of incubation at 37◦C reaction was stopped with
cold HClO4 (0.5 M) followed by vigorously shaking using a
vortex. The mixture was centrifuged at 15,800 × g during 5
min at 4◦C. Supernatant was transferred to a clean tube and
neutralized with potassium carbonate (K2CO3, 0.5 M), frozen
at −80◦C for 30 min, thawed, centrifuged, and finally filtered
through 0.22 µM membrane prior to injection into the HPLC.
Results were expressed in µmol h−1 mg−1 of protein. One
unit of IMPDH activity is defined as the amount of enzyme
necessary to catalyze the oxidation of 1 µM of IMP to XMP per
min at 37◦C. Chromatographic procedures for IMPDH activity
determination were only minimally modified (acetonitrile was
replaced for methanol) from the HPLC conditions described
above for purine metabolites quantification. Stationary phase
consisted of a Hypersil 125 × 4.6 mm, 3 µm particle size
column (Thermo Scientific, USA). Mobile phase consisted of
a binary gradient from 100% Buffer A (KH2PO4, 100 mM
with 8 mM tetrabutylammonium hydrogen sulfate, pH 6.0) to
100% Buffer B (KH2PO4 with methanol 30%), in a total run
time of 26min at constant flow rate of 1.2 mL per min. A
standard curve of XMP (0.39–50 µM) was used to calculate
IMPDH activity. Detection signal was monitored at 254 nm.
Peak identification was confirmed by retention time, absorption
spectrum and whether the sample showed overlapping peaks
following enrichment with the standard.
Additionally, 8 samples of plasma from dolphins were
collected in order to determine uricase activity. Uricase
(EC 1.7.3.3) activity was measured by fluorescence in a
microplate reader (Synergy 4, BioTek) using the Amplex Red
Uric Acid/Uricase Assay kit (Molecular Probes, Eugene, OR)
according to the manufacturer’s instructions. One unit of uricase
is defined as the amount of enzyme necessary to convert 1 µmole
of uric acid to allantoin per minute at pH 8.5 and 25◦C.
Total Soluble Protein Content
All data were standardized to mg of protein. Total soluble
proteins were quantified as described by Bradford (1976) using
a commercial kit adapted for use in a microplate reader (Bio-
Rad Laboratories, Hercules, CA, USA). Bovine serum albumin
(BSA) was used as standard, and a standard curve (0.005–0.2mg
mL−1) was used for calculations. Results were expressed in mg of
protein mL−1.
Statistical Analyses
Data were grouped by species. Normality and homoscedasticity
of the data were tested using Kolmogorov–Smirnov and Levene
tests, respectively. Given the non-normal distribution of the data,
significant differences were determined with Mann–Whitney
U-tests (Zar, 2009). All statistical analyses were performed
using Statistica R© 6.0 and SPSS v22 (IBM, Armonk, NY, USA).
Statistical significance was considered when p < 0.05. Data are
presented as median and 25th–75th percentiles.
RESULTS
Concentration of Purine Metabolites
The concentration of purine metabolites was determined to
elucidate purine requirement differences in RBC and plasma
from dolphins and humans. These results are summarized for
RBC in Table 1 and for plasma in Table 2. In RBC from humans
HX, IMP, NAD+, AMP, ADP, GTP, ATP were detected; in
addition to these, GDP was identified in RBC from dolphins.
Determination of HX, xanthine, uric acid, IMP, adenosine,
NAD+, AMP, ADP, GDP, GTP, and ATP was achieved in plasma
of both species. Adenosine levels in RBC of both species were
below the detection limit (0.39µMmL−1). In RBC from dolphins
the concentrations of NAD+ (U = 0.001, p < 0.01) and AMP
(U = 12.0, p < 0.01) were higher than in humans. HX (U = 20.0,
p < 0.01), ADP (U = 27.0, p < 0.01), GTP (U = 21.0, p < 0.01),
and ATP (U =7.0, p < 0.01) concentrations were higher in RBC
from humans than in dolphins. Higher HX (U = 32.0, p = 0.02)
and IMP (U = 26.0, p = 0.049) concentrations were found in
plasma from dolphins than in humans. Plasma ADP (U = 5.0,
p < 0.01), GTP (U = 27.0, p < 0.01), and ATP (U = 19.0,
TABLE 1 | Purine metabolite concentrations (µmol mg−1 of protein) in
erythrocytes (RBC) from humans and bottlenose dolphins (n = 12 for each
species).
Human Bottlenose dolphin
(µmol mg−1 of protein) (µmol mg−1 of protein)
HX 0.18 (0.11−0.24)* 0.057 (0.051−0.084)
IMP 0.07 (0.05−0.72) 0.18 (0.12−0.27)
NAD+ 0.004 (0.003−0.006) 0.09 (0.05−0.12)*
AMP 0.08 (0.07−0.17) 0.37 (0.23−0.57)*
GDP – 0.06 (0.05−0.07)
ADP 0.31 (0.28−0.37)* 0.24 (0.19−0.28)
GTP 0.06 (0.06−0.09)* 0.04 (0.03−0.05)
ATP 0.84 (0.45−0.92)* 0.09 (0.05−0.15)
Data are presented as median (25th-75th percentiles). *Significant differences between
species, p < 0.05. HX, hypoxanthine; IMP, inosine monophosphate; NAD+, nicotinamide
adenine dinucleotide; AMP, adenosine monophosphate; GDP, guanine diphosphate; ADP,
adenosine diphosphate; GTP, guanine triphosphate; ATP, adenosine triphosphate.
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TABLE 2 | Purine metabolite concentrations (µmol mg−1 of protein) in
plasma from humans and bottlenose dolphins (n = 12 for each species).
Human Bottlenose dolphin
(µmol mg−1 of protein) (µmol mg−1 of protein)
HX 0.07 (0.04−0.14) 0.33 (0.22−0.54)*
Xanthine 0.28 (0.21−0.48) 0.22 (0.14−0.24)
Uric acid 7.01 (4.71−9.28)* 0.44 (0.24−0.76)
IMP 0.12 (0.09−0.18) 0.25 (0.15−0.38)*
Inosine 0.15 (0.09−0.26) 0.12 (0.09−0.17)
NAD+ 0.12 (0.07−0.18) 0.17 (0.10−0.25)
Adenosine 0.04 (0.02−0.11) 0.016 (0.015−0.017)
AMP 0.06 (0.05−0.12) 0.05 (0.04−0.06)
GDP 0.04 (0.04−0.05) 0.04 (0.03−0.05)
ADP 0.07 (0.06−0.10)* 0.03 (0.02−0.04)
GTP 0.05 (0.04−0.069)* 0.04 (0.030−0.04)
ATP 0.04 (0.03−0.05)* 0.02 (0.01−0.03)
Data are presented as median (25th-75th percentiles). *Significant differences between
species, p < 0.05. HX, hypoxanthine; IMP, inosine monophosphate; NAD+, nicotinamide
adenine dinucleotide; AMP, adenosine monophosphate; GDP, guanine diphosphate; ADP,
adenosine diphosphate; GTP, guanine triphosphate; ATP, adenosine triphosphate.
p< 0.01) concentrations were lower in dolphins than in humans.
Plasma uric acid concentration was >16-fold lower in dolphins
than in humans (U = 0.001, p < 0.01).
Enzyme Activities
The data of HGPRT and IMPDH activities in RBC are
summarized in Table 3. HGPRT activity was measured by its
central role to recycle nucleotides through the salvage pathway.
The activity of HGPRT in RBC from dolphins was lower than
in humans (U = 0.001, p < 0.01). In RBC from dolphins, a
low HGPRT activity is apparently sufficient to recycle HX to
IMP, since IMP concentration was not different from humans.
In plasma from dolphins, HGPRT activity was 3.25 (1.23–3.95)
nmol h−1 mg−1 of protein and may indicate a role to balance
or deliver purine requirements to tissues/organs committed to
hypoxia/ischemia associated to diving. The activity of HGPRT
was below the detection limit (6.75 nmol mL−1 h−1) in 58.33%
of human plasma samples [0.33 (0.260–1.899) nmol h−1 mg−1
of protein], and in three of these samples, was close to the value
obtained for blanks. IMPDH represents a rate-limiting enzyme
to guanine nucleotide biosynthesis in the de novo pathway.
There were no statistically significant differences in RBC IMPDH
activity between dolphins and humans. This suggests that there
is no significantly higher contribution of de novo pathway to
modulation of purine metabolism in dolphins than in terrestrial
mammals. Uricase activity was determined in plasma from
dolphins in order to test if this enzyme directly influenced lower
levels of xanthine and uric acid. There was no evidence of uricase
activity.
DISCUSSION
Evidence suggests an enhancement to recycle purines under
circumstances like ischemia and prolonged fasting in seals.
TABLE 3 | Enzyme activity of hypoxanthine-guanine phosphorybosil
transferase (HGPRT, nmol h−1 mg−1 of protein) and inosine
monophosphate dehydrogenase (IMPDH, µM h−1 mg−1 of protein) in
erythrocytes (RBC) from humans and bottlenose dolphins (n = 12 for each
species).
HGPRT activity IMPDH activity
(nmol h−1 mg−1 of
protein)
(µmol h−1 mg−1 of
protein)
Human 123.04 (102.17−140.99)* 0.032 (0.024−0.041)
Bottlenose dolphin 41.81 (33.73−45.36) 0.021 (0.13−0.036)
Data are presented as median (25th-75th percentiles). *Significantly different p < 0.05.
For instance, ringed seals possess the ability to maintain HX
levels below terrestrial mammals under ischemic conditions
(Elsner et al., 1998) and northern elephant seals increase
purine recycling and catabolism during prolonged fasting
(Soñanez-Organis et al., 2012). Further, purine metabolism
modulation is species-specific, even among diving mammals
(López-Cruz et al., 2014). We measured the concentration of
purine metabolites relating to several steps of purine pathways,
HGPRT as indicator of purine salvage pathway and IMPDH as
indicator of de novo biosynthesis in dolphin plasma and RBC.
In northern elephant seals, prolonged fasting increases plasma
HGPRT activity (Soñanez-Organis et al., 2012). Similarly, in
this study, plasma HX and IMP concentrations (i.e., HGPRT
substrate and product, respectively) were significantly higher in
dolphins than humans. This suggests an efficient mechanism
to prevent two detrimental processes in dolphins; namely,
(1) accumulation of non-recyclable purines (xanthine, uric
acid), and (2) overproduction of ROS (mediated by increased
XO activity as a consequence of ischemia/reperfusion and
hypoxia/reoxygenation cycles associated to diving). HGPRT
activity in plasma of dolphins could offer an advantage to salvage
and supply nucleotide precursors to cells or tissues that require
returning to basal levels following an episode of ischemia and/or
hypoxia. For example, it is possible that under ischemic/hypoxic
conditions, nucleosides and oxypurines are released to plasma,
a fraction of purines are delivered directly to RBC to produce
new nucleosides and nucleotides (Dománski et al., 2012). High
permeability of RBC from bottlenose dolphins and humans
to nucleosides and glucose (Craik et al., 1997) could ensure
suitable levels of adenine and guanine nucleotides inside these
cells. To our knowledge, plasma HGPRT activity has not been
previously reported in humans. A specific search for similar
publications in health area databases Pubmed, EBSCO, Springer
Link and ScienceDirect was performed on May 20th, 2015 using
the following keywords “hypoxanthine-guanine phosphoribosyl
transferase,” “activity,” “human plasma.” The displayed results
were 657 publications from the year 1980 to 2015; however, none
of these publications report HGPRT activity in human plasma
samples. At this time, we cannot discard HGPRT activity levels
detected in human plasma samples being associated to hemolysis.
Purine metabolism in human RBC is apparently limited to
salvage and catabolism pathways since the de novo pathway is
not active in these cells (Lowy and Dorfman, 1970; Skotnicka
et al., 2008; Dudzinska et al., 2010). However, IMPDH activity has
Frontiers in Physiology | www.frontiersin.org 5 June 2016 | Volume 7 | Article 213
López-Cruz et al. Purine Metabolism in Dolphins and Humans
been reported in RBC (Montero et al., 1995). Intraerythrocytic
activity of PNP, an enzyme related to purine salvage, is lower
in marine mammals (dolphins and northern elephant seals)
than in terrestrial mammals (Craik et al., 1997; López-Cruz
et al., 2014). In this study, intraerythrocytic HGPRT activity
was lower in dolphins than in humans. These results suggest
that purine recycling in RBC from dolphins is lower than in
humans. Lower HX and higher (NS) IMP concentrations in RBC
from dolphins suggest an efficient reutilization of purines via
the HGPRT-IMP pathway than in humans. Even though ATP
and ADP concentrations were lower in RBC from dolphins,
AMP concentrations were higher than in humans. It is possible
that in dolphins, ATP degradation could be modulated in order
to avoid accumulation of non-recyclable purines (i.e. xanthine
and uric acid) and to optimize ATP reserves. In accordance
with this suggestion, lower HX accumulation has been reported
in ringed seal kidney and heart than in the same tissues of
domestic pig in response to in vitro ischemia (Elsner et al.,
1998). In RBC from dolphins in this study, ATP conservation
was not evident since ATP concentration was significantly lower
than in humans. At this time, we cannot discard low ATP
and ADP concentrations in RBC from bottlenose dolphins
being a consequence of breath-hold diving, since during blood
sampling dolphins were at static apnea. It is possible that
such apneic bouts are tantamount to preconditioning and
which could lead to reduced content of purine metabolites.
Furthermore, in humans, RBC ATP is not recycled from HX
since humans lack the enzyme adenylosuccinate synthetase
(Simmonds et al., 1989; Schuster and Kenanov, 2005). The
activity of IMPDH, a rate-limiting enzyme for guanine nucleotide
metabolism (Ignoul and Eggermont, 2005), was not different
between humans and dolphins. Thus, recycling by the salvage
pathway, taking advantage of preformed purines seems to be
sufficient to maintain the pool of guanine nucleotides in both
species. GTP levels are considered relatively low in RBC from
humans (Simmonds et al., 1989). IMPDH activity in healthy
subjects has been reported in the range of 4–183 pmol h−1 mg−1
of protein (Montero et al., 1995).
Accumulation of non-recyclable purines is of clinical
importance in humans. There was no significant difference
in plasma xanthine concentration between humans and
dolphins; however, uric acid content was >16-fold higher in
humans. Considering plasma HGPRT activity, HX and IMP
concentrations, we suggest that dolphins recycle purines at
a higher rate than humans. However, a special consideration
should be made for the catabolism pathway. Evolutionary
divergence of nitrogen compound elimination could contribute
to uric acid concentration differences since this is the final
product of purine catabolism in primate mammals. In marine
mammals the final product is allantoin (Skinner et al., 2006).
Since no uricase activity was found in plasma from dolphins,
purine recycling pathway appears to play an essential role to
avoid purine over-accumulation. Further, the antioxidant role
of uric acid may convey an advantage to the observed levels of
this by-product in human plasma (Ames et al., 1981). Uric acid
is responsible of 60–70% of the antioxidant capacity in plasma
from humans (Proctor, 2008). Purine metabolism is highly
influenced by diet. In dolphins from managed populations,
protein- and purine-rich diets seem to predispose ammonium
urate nephrolithiasis (Smith et al., 2014). Purine recycling in
plasma from wild dolphins should be investigated to compare
differences in recycling rates between organisms with diverse
diets.
In a previous study, the activity of two of the enzymes
related to purine metabolism, PNP and XO in the same dolphin
population was analyzed (López-Cruz et al., 2014). No differences
between XO activity in plasma from humans and dolphins were
found; however, we did find lower PNP activity in RBC from
dolphins. Our results for PNP activity are in agreement with
those reported in the literature (Sandberg et al., 1955; Craik et al.,
1997) and could in part explain the lower HX levels observed.
Since a previous report suggested rapid entry of adenosine into
dolphin erythrocytes (Craik et al., 1997), and given that further
information is not available, at this time we cannot discard the
possibility that other purine nucleosides, such as HX, could be
similarly transported in RBC to/from tissues.
ATP-binding cassette transporters could contribute to
maintain homeostasis in dolphin RBC. Literature on purine
transporters in marine mammals is scarce. Craik et al. (1997)
examined nucleoside transport in erythrocytes from bottlenose
dolphins and reported functional properties similar to those
of es transporters in human RBC. Even if HX is taken outside
the erythrocytes, inosine is not a source of energy in RBC from
bottlenose dolphins and PNP is lower in comparison with pigs
and humans (Craik et al., 1997); under circumstances of ATP
depletion such as diving or exercise HX levels could be delivered
to RBC, to take advantage of preformed purines and recover
energy levels rapidly; this has been suggested for horses (Jarvis
and Harris, 1998).
In conclusion, these results indicate a specific purine
metabolite modulation in plasma from dolphins, particularly for
avoiding accumulation of non-recyclable purines. Considering
RBC are highly permeable but are not highly metabolically
active and that purine metabolism has been shown to be tissue-
specific (Soñanez-Organis et al., 2012), in dolphins the circulating
HGPRT-IMP pathway may contribute to providing purine
nucleosides and nucleotides to other cells or tissues, particularly
to those with high ATP and GTP requirements. Enhancement of
circulating purine salvage pathway could provide a mechanism
for rapid replacement of nucleotides to other cells or tissues
depleted during diving or swimming in bottlenose dolphin.
Plasma HGPRT activity in bottlenose dolphins suggests an
efficient mechanism for avoiding accumulation of non-recyclable
purines. The results from this study suggest that purine recycling,
in addition to contributing to reestablish important nucleobases
concentrations, may provide an additional mechanism for
marine mammal tissues to prevent ROS overproduction and
to avoid oxidative damage after routine diving cycles. Further
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investigation of purine de novo synthesis, salvage and catabolism
pathways in other tissues in marine and terrestrial mammals is
required.
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